GB202214800D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB202214800D0
GB202214800D0 GBGB2214800.1A GB202214800A GB202214800D0 GB 202214800 D0 GB202214800 D0 GB 202214800D0 GB 202214800 A GB202214800 A GB 202214800A GB 202214800 D0 GB202214800 D0 GB 202214800D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2214800.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Of Luebeck, University of
Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Universitaet zu Luebeck
Tocris Cookson Ltd
Original Assignee
Of Luebeck, University of
Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Universitaet zu Luebeck
Tocris Cookson Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Of Luebeck, University of, Helmholtz Zentrum fuer Infektionsforschung HZI GmbH, Universitaet zu Luebeck, Tocris Cookson Ltd filed Critical Of Luebeck, University of
Priority to GBGB2214800.1A priority Critical patent/GB202214800D0/en
Publication of GB202214800D0 publication Critical patent/GB202214800D0/en
Priority to PCT/GB2023/052604 priority patent/WO2024074849A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2214800.1A 2022-10-07 2022-10-07 Compounds Ceased GB202214800D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2214800.1A GB202214800D0 (en) 2022-10-07 2022-10-07 Compounds
PCT/GB2023/052604 WO2024074849A1 (en) 2022-10-07 2023-10-06 Proteolysis-targeting chimeras against the papain-like protease of sars-cov-2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2214800.1A GB202214800D0 (en) 2022-10-07 2022-10-07 Compounds

Publications (1)

Publication Number Publication Date
GB202214800D0 true GB202214800D0 (en) 2022-11-23

Family

ID=84818157

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2214800.1A Ceased GB202214800D0 (en) 2022-10-07 2022-10-07 Compounds

Country Status (2)

Country Link
GB (1) GB202214800D0 (en)
WO (1) WO2024074849A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN208237661U (en) 2018-06-27 2018-12-14 杨瑞士 A kind of lighting fixture
WO2020069125A1 (en) 2018-09-28 2020-04-02 Dana-Farber Cancer Institute, Inc. Degraders of hepatitis c virus ns3/4a protein
WO2021231778A1 (en) 2020-05-13 2021-11-18 Kymera Therapeutics, Inc. Coronavirus protease degraders and uses thereof
WO2022070048A1 (en) 2020-09-29 2022-04-07 Cadila Healthcare Limited Novel amide derivatives
WO2022081827A1 (en) 2020-10-14 2022-04-21 Dana-Farber Cancer Institute, Inc. Chimeric conjugates for degradation of viral and host proteins and methods of use
WO2022169891A1 (en) 2021-02-08 2022-08-11 Arizona Board Of Regents On Behalf Of The University Of Arizona Compounds, compositions, and methods of using the same
JP2024512428A (en) 2021-03-12 2024-03-19 インフェックス・セラピューティクス・リミテッド antiviral compounds
CN113735937B (en) 2021-10-09 2023-10-20 深圳湾实验室坪山生物医药研发转化中心 Stable polypeptide protein covalent inhibitor of papain-like protease PLpro of targeted 2019 novel coronavirus

Also Published As

Publication number Publication date
WO2024074849A1 (en) 2024-04-11

Similar Documents

Publication Publication Date Title
GB202201996D0 (en) Compounds
GB202305212D0 (en) Compounds
GB202303419D0 (en) Compounds
GB202303387D0 (en) Compounds
GB202303230D0 (en) Compounds
GB202302871D0 (en) Compounds
GB202302237D0 (en) Tryptophan-based compounds
GB202302032D0 (en) Compounds
GB202301012D0 (en) Compounds
GB202301008D0 (en) Compounds
GB202301000D0 (en) Compounds
GB202300995D0 (en) Compounds
GB202301024D0 (en) Compounds
GB202300922D0 (en) Compounds
GB202300021D0 (en) Compounds
GB202219706D0 (en) Compounds
GB202219534D0 (en) Compounds
GB202217844D0 (en) Compounds
GB202217330D0 (en) Compounds
GB202216695D0 (en) Compounds
GB202215664D0 (en) Compounds
GB202215534D0 (en) Compounds
GB202214800D0 (en) Compounds
GB202214796D0 (en) Compounds
GB202213798D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)